European Council Approves First-Ever Analysis Of Drug Prices With Look At IP Rights
[William New for IP Watch, Link (CC-BY-NC-SA)] The 28 European Union governments today were expected to give final approval to a first-ever plan to analyse medicines competition in Europe, with reference to drug prices, generics and biosimilars, and intellectual property…
